Sarasin & Partners’s Monte Rosa Therapeutics GLUE Stock Holding History

Sarasin & Partners’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$243K	Hold
2024 Q1	$459K	Hold
2023 Q4	$368K	Hold
2023 Q3	$312K	Hold
2023 Q2	$446K	Hold
2023 Q1	$507K	Hold
2022 Q4	$495K	Hold
2022 Q3	$532K	Hold
2022 Q2	$629K	Buy